Seattle Cannabis Blockbuster Set to Double Sales in Next 2 Years!
Thanks to a recent reorganization, acquisitions, and strategic partnerships, one Seattle cannabis blockbuster is poised for a massive expansion in the coming 24 months. With plans to double its annual sales in the next two years, this company’s shares could potentially skyrocket in value.

OTCMKTS:HLMAF - Halma Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 7
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$40.40
+0.30 (1.20%)

This chart shows the closing price for HLMAF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Halma Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HLMAF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HLMAF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 7 analysts offering 12 month price targets for Halma in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $40.40.

This chart shows the closing price for HLMAF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
New Aggressive Growth Stock
This stock targets a huge market and is set for hypergrowth.

Current Consensus is Hold

The current consensus among 7 polled investment analysts is to hold stock in Halma. This rating has held steady since June 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 1 sell ratings
2/11/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
5/11/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
8/9/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 5 hold ratings
  • 2 sell ratings
11/7/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 2 sell ratings
2/5/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 2 sell ratings
5/6/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 2 sell ratings
7/5/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/4/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral
7/15/2021UBS GroupReiterated RatingBuy
6/25/2021JPMorgan Chase & Co.Reiterated RatingUnderweight
6/18/2021Berenberg BankReiterated RatingHold
6/14/2021BarclaysReiterated RatingEqual Weight
6/11/2021Credit Suisse GroupReiterated RatingOutperform
4/20/2021UBS GroupUpgradeNeutral ➝ Buy
4/16/2021Berenberg BankReiterated RatingHold
3/25/2021BarclaysReiterated RatingEqual Weight
1/20/2021Berenberg BankReiterated RatingHold
12/7/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
11/20/2020BarclaysReiterated RatingEqual Weight
11/20/2020Morgan StanleyReiterated RatingEqual Weight
10/15/2020Berenberg BankReiterated RatingHold
10/12/2020Morgan StanleyReiterated RatingEqual Weight
7/20/2020Jefferies Financial GroupReiterated RatingUnderperform
7/16/2020BarclaysReiterated RatingEqual Weight
7/16/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
7/14/2020UBS GroupReiterated RatingNeutral
7/8/2020JPMorgan Chase & Co.Reiterated RatingUnderweight
4/23/2020Peel HuntDowngradeBuy ➝ Hold
4/22/2020UBS GroupReiterated RatingNeutral
1/13/2020The Goldman Sachs GroupUpgradeNeutral ➝ Buy
4/3/2019Jefferies Financial GroupDowngradeBuy ➝ Hold
(Data available from 8/5/2016 forward)
Halma logo
Halma plc provides technology solutions in the safety, health, and environmental markets. It operates through four segments: Process Safety, Infrastructure Safety, Environmental & Analysis, and Medical. The Process Safety segment offers specialized interlocks that control critical processes safely; instruments that detect flammable and hazardous gases; and explosion protection and corrosion monitoring systems. This segment serves the gas detection, industrial access control, pressure management, and safe storage and transfer markets. The Infrastructure Safety segment provides fire detection systems, specialist fire suppression systems, elevator safety systems, people and vehicle flow technologies, and security sensors. It serves the fire detection and suppression, and elevator markets. The Environmental & Analysis segment offers opto-electronic technology and sensors, flow gap measurement instruments, and gas conditioning products, as well as solutions for environmental data recording, water quality testing, water distribution network monitoring, and UV water treatment. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Medical segment provides devices that assess eye health; assist with eye surgery and primary care applications; critical fluidic components used by medical diagnostics and original equipment manufacturers; and laboratory devices and sensor technologies used in hospitals to understand patient health. This segment serves the life sciences, health assessment, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
Read More

Today's Range

Now: $40.40
Low: $40.40
High: $40.40

50 Day Range

MA: $37.90
Low: $36.54
High: $41.04

52 Week Range

Now: $40.40
Low: $28.10
High: $41.04

Volume

13,100 shs

Average Volume

1,028 shs

Market Capitalization

$15.34 billion

P/E Ratio

52.46

Dividend Yield

N/A

Beta

0.74

Frequently Asked Questions

What sell-side analysts currently cover shares of Halma?

The following equities research analysts have issued research reports on Halma in the last year: Barclays PLC, Berenberg Bank, Credit Suisse Group AG, JPMorgan Chase & Co., Morgan Stanley, The Goldman Sachs Group, Inc., UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for HLMAF.

What is the current price target for Halma?

0 Wall Street analysts have set twelve-month price targets for Halma in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Halma in the next year.
View the latest price targets for HLMAF.

What is the current consensus analyst rating for Halma?

Halma currently has 1 sell rating, 4 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HLMAF, but not buy more shares or sell existing shares.
View the latest ratings for HLMAF.

What other companies compete with Halma?

How do I contact Halma's investor relations team?

Halma's physical mailing address is Misbourne Court Rectory Way, Amersham X0, HP7 0DE. The company's listed phone number is 44-14-9472-1111 and its investor relations email address is [email protected] The official website for Halma is www.halma.com.

Seattle Cannabis Blockbuster Set to Double Sales in Next 2 Years!
Thanks to a recent reorganization, acquisitions, and strategic partnerships, one Seattle cannabis blockbuster is poised for a massive expansion in the coming 24 months. With plans to double its annual sales in the next two years, this company’s shares could potentially skyrocket in value.